MedTrace Logo

Pleth Variability Index in Pulmonary Embolism

NCT06508112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-07-18

No results posted yet for this study

Summary

Pulmonary embolism(PE) is a ventilation/perfusion disorder caused by obstruction of the pulmonary artery, usually by a thrombus. The Pleth Variability Index(PVI) is a continuous, noninvasive indicator of dynamic perfusion index changes in photoplethysmography that occur in at least one respiratory cycle. The aim of this study is to evaluate the prognostic and mortality indicator role of PVI in patients with PE, hypothesizing that PVI could serve as a valuable guide in this disease where perfusion impairment is fundamental.

Based on our study, we determined that PVI could be a non-invasive, rapid, and objective tool for predicting disease progression and mortality in PE patients in the emergency department. Our study is the first to evaluate the PVI in PE.

Conditions

Interventions

DEVICE

Masimo Radical-7® Pulse CO-Oximeter

Masimo Radical-7® Pulse CO-Oximeter device was attached to the index finger of the patients in the supine position and photoplethysmographic perfusion index and plethysmographic variability index were measured noninvasively, rapidly and continuously.

Sponsors & Collaborators

  • Suleyman Demirel University

    lead OTHER

Principal Investigators

  • Teslime Eryavuz Şengül, M.D. · suleyman demirel university faculty of medicine

  • Hamit H Armağan, assoc prof · suleyman demirel university faculty of medicine

  • Furkan Ç Oğuzlar, asst prof · suleyman demirel university faculty of medicine

Eligibility

Min Age
18 Years
Max Age
93 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-03-31
Completion
2024-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06508112 on ClinicalTrials.gov